跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZAXINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ZAXINE
Authorized
STANDARD
ZAXINE
SALIX PHARMACEUTICALS INC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
63d656cb88915cd0
Company
SALIX PHARMACEUTICALS INC
Type
Standard
Approval Details
Approval Id
63d656cb88915cd0
Drug Approval Canada Name
ZAXINE
Product Name
ZAXINE
Status
Marketed
Status Date
2013-11-07
Original Market Date
2013-11-07
Din
02410702
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:12.28.30
Atc Original
A07AA11 RIFAXIMIN
Atc Name
a 07 aa 11
Aig Number
0154590001
Company Name
SALIX PHARMACEUTICALS INC
Company Address
400 Somerset Corporate Boulevard, Bridgewater, New Jersey, United States, 08807
Company Detail Path
/organization/salix-pharmaceuticals-inc-ridgeland-mississippi-united-states
Company Information
Pharmaceutical Company Name
SALIX PHARMACEUTICALS INC
Country Name
United States
Province Name
Mississippi
City Name
ridgeland,mississippi,country_us
Address
291 Highway 51 Ste A7
Active Ingredients
RIFAXIMIN
550 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
63d656cb88915cd0
Type
Standard
Back to Health Canada Approvals